i&i Biotech Fund invests more than €1 Million in Enzyre to help to advance diagnostic platform for hemophilia patients
Funds will be used to accelerate development of the platform, establish manufacturing capabilities and implement plans to expand platform beyond hemophilia A. PRAGUE, CZECH REPUBLIC, November 2, 2022 /EINPresswire.com/ -- Enzyre, a company …